Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

UV‐B exposure and calcium and/or vitamin D supplementation were protective factors; all others were risk factors.

Source: Direct and Indirect Social Determinants of Pre‐Eclampsia. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Integrating Social and Clinical Determinants of Pre‐Eclampsia: A Hierarchical Systematic Review and Conceptual Framework for Prevention

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Integrating Social and Clinical Determinants of Pre‐Eclampsia: A Hierarchical Systematic Review and Conceptual Framework for Prevention

Systematic review · Bjog · 2026

Original publication title

Integrating Social and Clinical Determinants of Pre‐Eclampsia: A Hierarchical Systematic Review and Conceptual Framework for Prevention

Mai‐Lei Woo Kinshella; Jeffrey N. Bone; Terteel Elawad; Hiten D. Mistry; Laney Poye; Eleni Tsigas; Deepika Devadas; Violet Mateljan; Marie‐Laure Volvert; Marianne Vidler; Hannah Blencowe; Véronique Filippi; Laura A. Magee; Peter von Dadelszen; The PRECISE NetworkD'AlessandroUmbertoRocaAnnaJahHawanatuPrenticeAndrewMartinez‐AlvarezMelisaDialloBrahimaSesayAbdulSusoSambouNjieBaboucarrTourayFatimaIdrisYahayaKongiraFatoumataNdureModou F. S.GibbaLawrenceBahAbdoulieBahYorroTemmermanMarleenKoechAngelaOkiroPatriciaOmuseGeoffreyMwashigadiGraceAmondiMary GorettiJumaConsolataMutungaJosephMukhanyaMosesOkelloRobinWanjeOnesmusMwanikiIsaacOchiengMarvinMwadimeEmilySeveneEsperançaTchavanaCorssinoMacuacuaSalesioValaAnifaBoeneHelenaQuimiceLazaroMaculuveSoniaMandomandoInaciovon DadelszenPeterMageeLaura A.CraikRachelVolvertMarie‐LaureMistryHitenMendyThomasRussellDonnaMakangaPrestige TatendaMakachaLibertyMlamboReasonPostonLucillaTribeRachelMooreSophieSalisburyTatianaPapageorghiouArisNobleAlisonCraikRachelBlencoweHannahFilippiVeroniqueLawnJoySilverMattAkuzeJosephGazeleyUrsulaCartwrightJudithWhitleyGuyKrishnaSanjeevVidlerMarianneLiJing (Larry)BoneJeffWoo KinshellaMai‐Lei (Maggie)TuDomenaSandhuAshPickerillKellyCarillhoCarlaBarrattBenjamin

© 2026 The Author(s). BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

There are strong social factors alongside clinical factors associated with pre‐eclampsia incidence. Interwoven relationships between factors highlight the multifactorial aetiology of pre‐eclampsia. Many determinants were potentially modifiable, which provides actionable intervention points for clinical care and public health strategies.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To develop a comprehensive conceptual framework of the strongest risk factors and their relationships contributing to pre‐eclampsia incidence.

Source: Objective

Abstract: Search Strategy

Medline, Embase, Health Technology Assessments and Database of Abstracts of Reviews of Effects, Cochrane Library were searched.

Source: Search Strategy

Abstract: Selection Criteria

Reviews, randomized controlled trials and cohort studies (> 1000 participants), reporting social and clinical factors associated with pre‐eclampsia were included.

Source: Selection Criteria

Abstract: Data Collection and Analysis

The strongest factors, defined as those with at least moderate strength of association and quality of evidence using GRADE, were compiled from our previously published individual frameworks to create a combined conceptual framework. Indirect associations were searched and the strongest indirect factors were added.

Source: Data Collection and Analysis

Abstract: Main Results

The conceptual framework integrated 35 social and clinical determinants of pre‐eclampsia. Key modifiable factors included BMI, interlinked with chronic hypertension/elevated blood pressure in early pregnancy, type 2 diabetes mellitus, and obstructive sleep apnoea, as well as antenatal care attendance, interconnected with maternal/work stress and prenatal micronutrient supplementation. Other modifiable factors included smoking, antiphospholipid syndrome, infection, exposure to occupational hazards, distance to health facility, maternal heat exposure in early gestation, and UV‐B exposure.

Source: Main Results

Abstract: Conclusion

There are strong social factors alongside clinical factors associated with pre‐eclampsia incidence. Interwoven relationships between factors highlight the multifactorial aetiology of pre‐eclampsia. Many determinants were potentially modifiable, which provides actionable intervention points for clinical care and public health strategies.

Source: Conclusion
Authors’ abstract

ABSTRACT

Background

Pre‐eclampsia is a leading cause of maternal and perinatal morbidity and mortality, with risk factors reported across a vast literature base fragmented between social and clinical factors.

Objective

To develop a comprehensive conceptual framework of the strongest risk factors and their relationships contributing to pre‐eclampsia incidence.

Search Strategy

Medline, Embase, Health Technology Assessments and Database of Abstracts of Reviews of Effects, Cochrane Library were searched.

Selection Criteria

Reviews, randomized controlled trials and cohort studies (> 1000 participants), reporting social and clinical factors associated with pre‐eclampsia were included.

Data Collection and Analysis

The strongest factors, defined as those with at least moderate strength of association and quality of evidence using GRADE, were compiled from our previously published individual frameworks to create a combined conceptual framework. Indirect associations were searched and the strongest indirect factors were added.

Main Results

The conceptual framework integrated 35 social and clinical determinants of pre‐eclampsia. Key modifiable factors included BMI, interlinked with chronic hypertension/elevated blood pressure in early pregnancy, type 2 diabetes mellitus, and obstructive sleep apnoea, as well as antenatal care attendance, interconnected with maternal/work stress and prenatal micronutrient supplementation. Other modifiable factors included smoking, antiphospholipid syndrome, infection, exposure to occupational hazards, distance to health facility, maternal heat exposure in early gestation, and UV‐B exposure.

Conclusion

There are strong social factors alongside clinical factors associated with pre‐eclampsia incidence. Interwoven relationships between factors highlight the multifactorial aetiology of pre‐eclampsia. Many determinants were potentially modifiable, which provides actionable intervention points for clinical care and public health strategies.

Publication and source details

Original title: Integrating Social and Clinical Determinants of Pre‐Eclampsia: A Hierarchical Systematic Review and Conceptual Framework for Prevention

Mai‐Lei Woo Kinshella; Jeffrey N. Bone; Terteel Elawad; Hiten D. Mistry; Laney Poye; Eleni Tsigas; Deepika Devadas; Violet Mateljan; Marie‐Laure Volvert; Marianne Vidler; Hannah Blencowe; Véronique Filippi; Laura A. Magee; Peter von Dadelszen; The PRECISE NetworkD'AlessandroUmbertoRocaAnnaJahHawanatuPrenticeAndrewMartinez‐AlvarezMelisaDialloBrahimaSesayAbdulSusoSambouNjieBaboucarrTourayFatimaIdrisYahayaKongiraFatoumataNdureModou F. S.GibbaLawrenceBahAbdoulieBahYorroTemmermanMarleenKoechAngelaOkiroPatriciaOmuseGeoffreyMwashigadiGraceAmondiMary GorettiJumaConsolataMutungaJosephMukhanyaMosesOkelloRobinWanjeOnesmusMwanikiIsaacOchiengMarvinMwadimeEmilySeveneEsperançaTchavanaCorssinoMacuacuaSalesioValaAnifaBoeneHelenaQuimiceLazaroMaculuveSoniaMandomandoInaciovon DadelszenPeterMageeLaura A.CraikRachelVolvertMarie‐LaureMistryHitenMendyThomasRussellDonnaMakangaPrestige TatendaMakachaLibertyMlamboReasonPostonLucillaTribeRachelMooreSophieSalisburyTatianaPapageorghiouArisNobleAlisonCraikRachelBlencoweHannahFilippiVeroniqueLawnJoySilverMattAkuzeJosephGazeleyUrsulaCartwrightJudithWhitleyGuyKrishnaSanjeevVidlerMarianneLiJing (Larry)BoneJeffWoo KinshellaMai‐Lei (Maggie)TuDomenaSandhuAshPickerillKellyCarillhoCarlaBarrattBenjamin

Bjog · 2026

* Correspondence:
Peter von Dadelszen (pvd@kcl.ac.uk)
© 2026 The Author(s). BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. UK Research and Innovation10.13039/100014013

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:26:31.160537+00:00

DOI: 10.1111/1471-0528.70240 · PMC13572890